These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. New nitroglycerin formulations: transdermal and transmucosal nitroglycerin. Abrams J Z Kardiol; 1985; 74 Suppl 4():10-5. PubMed ID: 3938113 [No Abstract] [Full Text] [Related]
10. [Nitrate derivatives and congestive cardiac failure in infants. Pharmacological efficacy of transcutaneous administration devices]. Guillot M; Braud J; Leveque C; Rey E; Olive G; Iselin M Arch Fr Pediatr; 1986 Jan; 43(1):67. PubMed ID: 3085627 [No Abstract] [Full Text] [Related]
11. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731 [TBL] [Abstract][Full Text] [Related]
12. Acute decompensated heart failure: the shrinking role of inotropic therapy. Dec GW J Am Coll Cardiol; 2005 Jul; 46(1):65-7. PubMed ID: 15992637 [No Abstract] [Full Text] [Related]
13. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin]. Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215 [TBL] [Abstract][Full Text] [Related]
15. Optimal starting time of acquisition and feasibility of complementary administration of nitroglycerin with intravenous beta-blocker in multislice computed tomography. Sato K; Isobe S; Sugiura K; Mimura T; Yotsudake Y; Meno C; Kato M; Harada K; Murohara T J Comput Assist Tomogr; 2009; 33(2):193-8. PubMed ID: 19346844 [TBL] [Abstract][Full Text] [Related]
16. Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response. Gisolf J; Westerhof BE; van Dijk N; Wesseling KH; Wieling W; Karemaker JM J Am Coll Cardiol; 2004 Aug; 44(3):588-93. PubMed ID: 15358026 [TBL] [Abstract][Full Text] [Related]
17. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603 [TBL] [Abstract][Full Text] [Related]
18. Do medications affect vital signs in the prehospital treatment of acute decompensated heart failure? Sporer KA; Tabas JA; Tam RK; Sellers KL; Rosenson J; Barton CW; Pletcher MJ Prehosp Emerg Care; 2006; 10(1):41-5. PubMed ID: 16418090 [TBL] [Abstract][Full Text] [Related]
19. Overview of current noninodilator therapies for acute heart failure syndromes. Stough WG; O'Connor CM; Gheorghiade M Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822 [TBL] [Abstract][Full Text] [Related]
20. Changes in the numeric descriptive scale for pain after sublingual nitroglycerin do not predict cardiac etiology of chest pain. Diercks DB; Boghos E; Guzman H; Amsterdam EA; Kirk JD Ann Emerg Med; 2005 Jun; 45(6):581-5. PubMed ID: 15940087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]